Neuphoria Therapeutics NEUP
NASDAQ NEUP
$2.71 +0.02 (+0.74%)
At close: Nov 11, 2026 · 4:00 PM EST

Neuphoria Therapeutics (NEUP) FCF Margin (2020 - 2025)

Updated

Neuphoria Therapeutics' FCF Margin was -1056.07% in FY2026 (year ended Jun 30, 2026), down 1056.56 percentage points from 0.49% in FY2025.

Analysis

Neuphoria Therapeutics (NEUP) FCF Margin (2020 - 2025) Analysis & Trends

From FY2020 onward, Neuphoria Therapeutics has reported FCF Margin for 5 fiscal years.

  • FCF Margin shows a four-year change of +7196.67 percentage points (FY2022 to FY2026).
  • The FY2026 figure marks the lowest annual FCF Margin since FY2023.
  • Per Business Quant data, FCF Margin in earlier fiscal years was 0.49% in FY2025, -96808.49% in FY2023 (-88555.75 pp) and -8252.74% in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 33.69%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 25.03%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 41.97%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.51%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 52.85%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.25%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 57.81%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 28.96%
10 Neuphoria Therapeutics 335.34 Mn 260.15 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 76.36%
Dec 31, 2024 -506.72%
Dec 31, 2020 -8,314.22%
API Access

Neuphoria Therapeutics FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=NEUP&period=max&api_key=YOUR_API_KEY